 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Main Lobby

 Procept BioRobotics Main Lobby

 Main Entrance

 Procept BioRobotics Main Entrance

SAN JOSE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PROCEPT...

PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose

REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) ( PROCEPT BioRobotics ), a global leader in surgical robotics, announced today the...

PROCEPT BioRobotics  Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation  Therapy for Prostate Cancer

In trading on Wednesday, shares of PROCEPT BioRobotics Corp (PRCT) crossed above their 200 day moving average of 35.67, changing hands as high as 35.76 per share. PROCEPT BioRobotics Corp...

PROCEPT BioRobotics Breaks Above 200-Day Moving Average - Bullish for PRCT

PROCEPT BioRobotics Co. (NASDAQ:PRCT Get Free Report) has received an average recommendation of Moderate Buy from the seven research firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to ...

PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives Average Recommendation of "Moderate Buy" from Analysts

PROCEPT BioRobotics Co. (NASDAQ:PRCT  Get Free Report) has received an average recommendation of Moderate Buy from the seven ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and five have ...

PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives $45.00 Average Target Price from Analysts

REDWOOD CITY, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (PROCEPT BioRobotics), a global leader in surgical robotics, announced today that it has successfully completed the first commercial Aquablation therapy procedures in Japan. The procedures were ...

PROCEPT BioRobotics(R) Announces First Commercial Aquablation Therapy Procedures in Japan

REDWOOD CITY, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the Company ), a surgical robotics company focused on advancing patient care by developing...

PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston

Highland Park Hospital adds second AquaBeam system, Swedish Hospital installs firstEVANSTON, Ill., Aug. 16, 2023 (GLOBE NEWSWIRE) -- NorthShore University HealthSystem (NorthShore) and PROCEPT BioRobotics announce a significant milestone in access to treatment of Benign Prostatic Hyperplasia (BPH). ...

NorthShore University HealthSystem offers expanded access to treat most common prostate ailment

Piper Sandler assumed coverage on shares of PROCEPT BioRobotics (NASDAQ:PRCT Free Report) in a research report sent to investors on Friday, MarketBeat.com reports. The brokerage issued an overweight rating and a $42.00 price target on the stock. PRCT has been the topic of a number of other research ...

PROCEPT BioRobotics (NASDAQ:PRCT) Coverage Initiated at Piper Sandler

Stock analysts at Piper Sandler initiated coverage on shares of PROCEPT BioRobotics (NASDAQ:PRCT  Get Free Report) in a note issued to investors on Friday, Marketbeat.com reports. The brokerage set an overweight rating and a $42.00 price target on the stock. Piper Sandler...

PROCEPT BioRobotics (NASDAQ:PRCT) Now Covered by Piper Sandler

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.

Watchers	289
52-Wk Low	$25.29
52-Wk High	$47.75

Market Cap	$1.47B
Volume (M)	220.00
52-Wk High	$47.75
52-Wk Low	$25.29

PRCT Procept BioRobotics Corp

About

Feed

News

Sentiment

Earnings

Fundamentals